Contact Details
Dr Abby Bloom
Chief Executive Officer
NSW
W www.acurate-flow.com...E healthinnovate@optus...
Acu Rate
Biomedical Flow Control
Physicians and nursing staff worldwide will find the innovative biomedical flow control technology developed by Acu Rate a remarkably safe and accurate alternative for delivering intravenous fluids to patients at home and in hospital. This single use and disposable device governs the rate at which fluids are infused into a patient. There is no need for an electric pump to drive the mechanism and virtually any type of fluid can be used regardless of its viscosity. Acu Rate flow controllers have an accuracy of 3% which is comparable to currently used volumetric electric pumps.
The advantages provided by this technology will be welcomed by home care patients and providers, hospitals and medical staff working in rural or remote locations, and those in conflict or emergency relief situations. A big appeal is Acu Rate’s ability to work without needing electricity or batteries. Its simplicity also means it is cheaper to manufacture, does not need maintenance and is easy to use.
The unit fits into a wide range of infusion sets already in use in different countries, avoiding compatibility problems. Distributors of infusion products will no longer have to provide or maintain pumps with the fluids they produce, health care facilities will appreciate the huge reduction in cost, home carers can set and forget the device, and emergency workers will have the equipment they need to better treat a greater number of patients.
Acu Rate’s products can replace a substantial proportion of the IV treatments that rely on electric or battery-operated pumps and also can take the place of roller-clamp IV sets. The cost is similar to an IV set but the accuracy is far superior. The controller can be designed to work with virtually any infusion or drug delivery system which greatly increases its market appeal.
Joint venture, manufacturing and distribution opportunities will emerge as Acu Rate begins to expand its operations worldwide.